HomeREGULATORY
REGULATORY

Industry Opposes Full Annual Price Revisions at LDP Hearing
(Nov.15.2017)

Pharma trade groups reiterated their opposition to full-scale annual drug price revisions at an industry hearing held by the ruling Liberal Democratic Party on November 14, with research-oriented drug makers calling for a limited scope of products to be covered by proposed “off-year” revisions, if they are to be implemented ...
(LOG IN FOR FULL STORY)